Program Leaders

项目负责人

• 批准号: 8375510
• 负责人: Louis M. Weiner
• 金额: $ 4.2万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8375510
• 关键词: Address; BAY 54-9085; Breast; Breast Cancer Detection; Breast Cancer Treatment; Canada; Cancer Center Support Grant; Clinical; Clinical Research; Clinical Trials; Comprehensive Cancer Center; Development; Disease; Faculty; Fellowship; Fostering; Funding; Future; Genetic screening method; Goals; Grant Review; Hematology; Hereditary Malignant Neoplasm; High Risk Woman; Joints; Medical; Medical Oncology; Medicine; Paper; Peer Review; Phase II Clinical Trials; Positioning Attribute; Prevention; Prevention strategy; Productivity; Program Effectiveness; Publications; Publishing; Research; Research Personnel; Research Project Grants; Residencies; Role; Running; Screening procedure; Staging; Training; Tumor Biology; Universities; Work; anastrozole; anticancer research; cancer therapy; clinical conference; design; graduate student; interest; malignant breast neoplasm; meetings; member; oncology; professor; programs; symposium; translational study

1.1. Program Leaders. Co-Leader (Clinical Research) - Claudine Isaacs, MD. Dr. Claudine Isaacs Is an Associate Professor in the Departments of Medicine and Oncology; she assumed the position of the Breast Cancer Program Clinical Co-Leader in 2001. Dr. Isaacs received her medical degree (MDCM) and residency training at McGill University (Canada). Following fellowship training in the Division of Medical Oncology at Georgetown University, she joined the faculty in the Department of Medicine (Division of Hematology and Medical Oncology) and she is now also a member in the Department of Oncology. Her research interests include genetic testing, breast cancer treatment, and prevention strategies for women at high risk of breast cancer. In addition, she has served as the PI of a variety of clinical trials In breast cancer screening and prevention, early-stage disease, and metastatic disease. Dr. Isaacs has been a longstanding member of the BC Program and serves as Co-Director of the Jess and Mildred Fisher Center for Familial Cancer Research of the Lombardi Comprehensive Cancer Center. She recently co-chaired a multi-institutional study of breast screening in genetically high-risk women and is currently conducting a Phase 2 trial of sorafenib and anastrazole in metastatic breast cancer.

1.1.项目负责人。联合负责人（临床研究）- Claudine Isaacs，医学博士。 Claudine Isaacs 博士是医学和肿瘤学系的副教授；她于 2001 年担任乳腺癌项目临床联合负责人。Isaacs 博士在加拿大麦吉尔大学获得医学学位 (MDCM) 和住院医师培训。在乔治敦大学肿瘤内科接受进修培训后，她加入了医学系（血液学和肿瘤内科），现在也是肿瘤科的成员。她 研究兴趣包括基因检测、乳腺癌治疗以及乳腺癌高危女性的预防策略。此外，她还担任多项乳腺癌筛查和预防、早期疾病和转移性疾病临床试验的PI。 Isaacs 博士是 BC 计划的长期成员，并担任 Lombardi 综合癌症中心 Jess 和 Mildred Fisher 家族癌症研究中心的联合主任。她最近共同主持了一项针对遗传高危女性进行乳腺筛查的多机构研究，目前正在进行索拉非尼和阿那曲唑治疗转移性乳腺癌的 2 期试验。